Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Nucleic Acid Testing Not Cost-Effective for WNV Screening of Donated Blood
No measure came close to the cost-effectiveness goal of $50,000 per quality-adjusted life-year gained.
Sign In
Don't yet have a username or password?
Register now for
Journal Watch e-mail alerts and unlimited online
access to articles 6 months after publication.
Subscribe now for
Full, immediate online access to all Journal Watch content and services.
Already a subscriber? Activate your subscription to receive full online access.
Get full site access with a 7-day site pass for $19